The drug from the common cold :: Consumers survey results of for 1 quarter of 2017

Consumers survey results of for 1 quarter of 2017 in category

Cold and Flu / The drug from the common cold

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	3	Nasivin (Dr. Reddy’s)	29.41%	5

1.	2	Евказолін Аква (Farmak)	29.41%	5

1.	4	Риназолін (Farmak)	29.41%	5

4.		Піносол (Zentiva)	23.53%	4

5.		Віброцил (Novartis OTC)	17.65%	3

5.	3	Назол (Bayer)	17.65%	3

5.	4	Фармазолін (Farmak)	17.65%	3

5.	3	Хьюмер (Delta Medical)	17.65%	3

9.	3	Aqua Maris (Jadran)	11.76%	2

9.	5	Lazorin (Boehringer Ingelheim)	11.76%	2

9.	4	Нафтизин (Farmak)	11.76%	2

9.	~	Но-соль (Farmak)	11.76%	2

9.	1	Нокспрей (Сперко Україна)	11.76%	2

9.	4	Синупрет (Bionorica)	11.76%	2

15.	~	DolphinThe products of TM Dolphin is not a medications. This is a dietary supplement, a cosmetic, or other kind of non-pharmaceutical products.');return false;"> (Alvogen Ukraine)	5.88%	1

15.	~	Quixx (Berlin-Chemie Menarini)	5.88%	1

15.		Галазолін (Polpharma S.A.)	5.88%	1

15.	5	Галазолін (ICN Polfa Rzeszow)	5.88%	1

15.	~	Грипостад Ріно (Nizhpharm)	5.88%	1

15.	5	Делуфен (Perrigo)	5.88%	1

15.	~	Каметон (Стома)	5.88%	1

15.	~	Ксилометазолін (ICN Polfa Rzeszow)	5.88%	1

15.	5	Ксимелін Екстра (Takeda)	5.88%	1

15.	5	Мілістан Сінус (Mili Healthcare)	5.88%	1

15.	~	Маример (Acino Pharma AG)	5.88%	1

15.		Мераліс (Jadran)	5.88%	1

15.	3	Отривін (Novartis OTC)	5.88%	1

15.	5	Санорин (Teva)	5.88%	1

–.	~	~~Риностоп (Bosnalijek)~~	~~5.88%~~	1

–.	5	IRS 19 (Abbott Laboratories)	0.00%	0

–.		Rint (Farmak)	0.00%	0

–.	5	Tyzine (Johnson & Johnson)	0.00%	0

–.		Аллертек (ICN Polfa Rzeszow)	0.00%	0

–.		Асініс (Perrigo)	0.00%	0

–.		Гайморин (Національна гомеопатична спілка)	0.00%	0

–.		Длянос (Novartis OTC)	0.00%	0

–.	5	Назалонг (Валартін Фарма)	0.00%	0

–.		Назолін-Дарниця (Darnitsa)	0.00%	0

–.		Ноксивін (Фармтехнологія)	0.00%	0

–.		Піновіт (Farmak)	0.00%	0

–.		Ріназал (Darnitsa)	0.00%	0

–.		Синус-ліфт Актив (Georg BioSystems)	0.00%	0

–.		СНУП (Stada)	0.00%	0

–.	5	Спрей назальний др. Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	0.00%	0

–.	4	Цинабсин (DHU)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2017, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.